Morgan Stanley Cuts Clorox Price Target to $87, Keeps Equal-Weight Rating
Morgan Stanley kept its equal-weight rating on Clorox and lowered its price target to $87 a share from $97. It also maintained equal-weight on Comstock Resources.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Morgan Stanley kept its equal-weight rating on Clorox shares but lowered its price target on the stock to $87 a share from $97.
The bank's ratings list also includes Comstock Resources, where the equal-weight rating was likewise maintained, with no change to the price target reported.
why it matters
A lower price target paired with an unchanged neutral rating points to a more cautious view on Clorox without a sharp shift in the bank's stance. For investors, such moves are one reference point among many when assessing the stock, not a signal to act.
tags
instruments
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗